Emcure Pharmaceuticals Ltd Share Price

Overview

Emcure Pharmaceuticals Ltd share price is currently ₹1,822.38, down by - ₹10.61 (0.58%) from its previous closing price of ₹1,832.99. The share price has declined -4.45% over the past month and gained 26.94% over the past year. The stock's 52-week low and high are ₹1,246.57 and ₹2,025.58, respectively. Emcure Pharmaceuticals Ltd has a market capitalisation of ₹ 35,340.00 Cr. The share price was last updated on 25 Aug 2026, 10:36 AM IST.

Emcure Pharmaceuticals Ltd

EMCURE

₹0.00

- ₹10.61

0.58%

Healthcare

₹0.00(%)1D

Updated: 25 Aug 2026, 10:36:34 am IST

Market Data

Open Price

₹1,834.66

Prev. Close

₹1,832.99

₹1,802.24

Day Low

₹1,847.78

Day High

₹1,246.57

52 Week Low

₹2,025.58

52 Week High

HealthcarePharmaceuticals & Drugs

CategoryLarge Cap

Fundamentals

Quick Bite

Price To Earnings Ratio

34.17

Sector PE

42.03

PB Ratio

7.79

Sector PB

5.82

EPS

53.34

Dividend Yield

0.28

Today's Volume

23.977 K

5 Day Avg. Volume

113.359 K

PEG Ratio

1.11

Market Cap.

₹ 35,340.00 Cr.

StockGro Trade views

Technical Analysis

Forecasts 🧭

Financials

Corporate Actions

Actions	Ex-Date	Record-Date
DividendsFinal Dividend of 36% at ₹3.6/Share	04-Sep-2026	04-Sep-2026
DividendsFinal Dividend of 30% at ₹3/Share	14-Aug-2025	14-Aug-2025

Mutual Fund Ownership

Mutual Fund Holder	Jun 26 Shares held	Jul 26 Shares held
Kotak Midcap Fund - Regular Plan - Growth	36.00 Lac	36.00 Lac no change
Nippon India Multi Cap Fund - Growth	17.25 Lac	17.17 Lac (0.45%)
Aditya Birla Sun Life ELSS Tax Saver Fund - IDCW	13.50 Lac	13.50 Lac no change
SBI Flexicap Fund - Regular Plan - Growth	11.29 Lac	11.29 Lac no change
HSBC Small Cap Fund - Regular Plan - Growth	8.85 Lac	8.85 Lac no change

Show all holdings

About Emcure Pharmaceuticals Ltd 👋

Emcure Pharmaceuticals Limited is an India-based pharmaceutical company, which is engaged in developing, manufacturing and globally marketing a range of pharmaceutical products across several major therapeutic areas. It offers a range of products and services under formulations, biologics and Active Pharmaceutical Ingredient (APIs). It operates across a wide scope of areas, including Gynecology, Cardiovascular, HIV Antivirals, VMN (Vitamins, Minerals & Nutrients), Pain/Analgesics, Nephrology, Oncology, Anti-Infective, Respiratory, CNS. Its brands include Orofer XT and Pause (Gynecological), Proxym (pain), Tenectase (CNS), Vylda (diabetology), Vitanova (VMN). Its API products include S-Amlodipine, Ferric Carboxymaltose, Ferrous Ascorbate and Eribulin. Its biologics business offers various products, including Elaxim (Tenecteplase), Vintor (Erythropoietin), TENECTASE (Tenecteplase). It has developed two platforms: Mammalian and Microbial.